Loading clinical trials...
Loading clinical trials...
This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Central Hospital, Nancy, France
NCT06397794 · Lyme Disease, Post Treatment Lyme Disease, and more
NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more
NCT07517406 · Gestational Diabetes Mellitus (GDM), Pregnancy Complications, and more
NCT06941025 · Fabry Disease, Pregnancy, and more
NCT06728722 · Muscle Loss, Extracellular Fluid Alteration, and more
Matthieu Dap
Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions